Eli Lilly, the makers of tirzepatide—which they sell as Mounjaro for diabetes and Zepbound for weight loss— announced recently that in its longest study yet on tirzepatide, the drug reduced the risk of people with prediabetes moving on to develop diabetes by 94% compared to those taking a placebo.

Wegovy, Zepbound and similar medications all lead to metabolic improvements, but scientists are starting to unpick the differences between them.

The weight management drug Zepbound will now be sold in lower-cost vials in addition to preloaded injector pens, according to manufacturer Eli Lilly. Here's what you need to know about how much the new drug costs,

A new study found that weekly injections of 2.4 mg of semaglutide could lower the risk of deaths related to COVID-19, marking another potential benefit of these blockbuster drugs.

To lose weight, millions of Americans have turned to prescription medications that treat diabetes like Wegovy, Ozempic and others. However, some say they can have serious side effects. CBS News senior investigative consumer correspondent Anna Werner spoke to a Pennsylvania woman who is warning others about rare complications she said she experienced from a weight loss drug that she says left her fighting for her life.